ALK21-006: Long-Term Study of Medisorb® Naltrexone (VIVITROL®)

NCT01218997 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

436

Enrollment

INDUSTRY

Sponsor class

Conditions

Alcoholism

Interventions

DRUG: Medisorb naltrexone 380 mg
DRUG: Oral naltrexone 50 mg

Sponsor

Alkermes, Inc.